| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology and Biology of Diseases, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606 [A. P., T. K., K. I., M. S., H. H.]; and Institute of Experimental Animals, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-31 [M. N.], Japan
Development of pulmonary adenomas (PAs) in mice is under the genetic control of multiple host genes. We have established a new set of SMXA recombinant inbred strains from PA-susceptible A/J and PA-resistant SM/J mice. The number of urethan-induced PAs was variable among substrains of the SMXA recombinant inbred strains, indicating the involvement of multiple genes. SMXA24 mice were highly resistant to PA, although they had susceptible alleles at all four known susceptibility genes, including kras2 and MHC. To identify the resistance gene in SMXA24, progeny of reciprocal F1 crosses and progeny of backcrosses to A/J were given urethan at 4 weeks of age and examined for induced PA at the age of 5 months. In reciprocal F1 cross progeny, the incidence of PA was very low, indicating that the resistance was a semidominant trait. Quantitative trait analysis of the backcross generation revealed significant linkages to loci on chromosome 12 (logarithm of odds score, 6.47) and chromosome 11 (logarithm of odds score, 4.35). To date, two PA resistance (PAR) genes, Par1 (located on chromosome 11) and Par2 (located on chromosome 18), have been reported. From the map position, one of the resistance genes on chromosome 11 was indistinguishable from Par1. However, another resistance gene on chromosome 12 was new, and we named this gene Par3. A likely candidate gene for Par3 is nPKC
, which is expressed exclusively in skin and lung and is down-regulated in PA. Par1 and Par3 seemed to act synergistically.
1 This study is supported by Grants-in-Aid for General Research and for Cancer Research from the Ministry of Education, Culture and Science, Japan, and from the Japanese Owner's Association, Tokyo, Japan.
2 To whom requests for reprints should be addressed. Phone: 81-075-753-4421; Fax: 81-075-753-4432; E-mail: hiai@med.kyoto-u.ac.jp.
Received 2/13/97. Accepted 5/15/97.
This article has been cited by other articles:
![]() |
M. Wang, Z. Zhang, Z. Zhang, H. Vikis, Y. Yan, Y. Wang, and M. You Fine Mapping and Candidate Gene Analyses of Pulmonary Adenoma Resistance 1, a Major Genetic Determinant of Mouse Lung Adenoma Resistance Cancer Res., March 15, 2007; 67(6): 2508 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang and M. You Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice Cancer Res., September 15, 2005; 65(18): 8158 - 8165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, H. Oikawa, J. Han, E. Kurose, and T. Maeda Genetic Analysis of Crown Size in the First Molars Using SMXA Recombinant Inbred Mouse Strains J. Dent. Res., January 1, 2004; 83(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, W. J. Lemon, G. Liu, Y. Wang, F. A. Iraqi, A. M. Malkinson, and M. You Fine Mapping and Identification of Candidate Pulmonary Adenoma Susceptibility 1 Genes Using Advanced Intercross Lines Cancer Res., June 15, 2003; 63(12): 3317 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, T. Ohno, A. Tsuji, M. Nishimura, and F. Horio Combinations of Nondiabetic Parental Genomes Elicit Impaired Glucose Tolerance in Mouse SMXA Recombinant Inbred Strains Diabetes, January 1, 2003; 52(1): 180 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
W J Lemon, H Bernert, H Sun, Y Wang, and M You Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays J. Med. Genet., September 1, 2002; 39(9): 644 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Sargent, J. R. Senft, D. T. Lowry, A. M. Jefferson, F. L. Tyson, A. M. Malkinson, A. E. Coleman, and S. H. Reynolds Specific Chromosomal Aberrations in Mouse Lung Adenocarcinoma Cell Lines Detected by Spectral Karyotyping: A Comparison with Human Lung Adenocarcinoma Cancer Res., February 1, 2002; 62(4): 1152 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tripodis, A. A. M. Hart, R. J. A. Fijneman, and P. Demant Complexity of Lung Cancer Modifiers: Mapping of Thirty Genes and Twenty-five Interactions in Half of the Mouse Genome J Natl Cancer Inst, October 3, 2001; 93(19): 1484 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Dwyer-Nield, B. Paigen, S. E. Porter, and A. M. Malkinson Quantitative trait locus mapping of genes regulating pulmonary PKC activity and PKC-alpha content Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L326 - L332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Wardlaw, T. H. March, and S. A. Belinsky Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions Carcinogenesis, July 1, 2000; 21(7): 1371 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogawa, M. Osanai, M. Obata, K. Ishizaki, and K. Kamiya Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines Carcinogenesis, November 1, 1999; 20(11): 2083 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kohno and J. Yokota1 How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis, August 1, 1999; 20(8): 1403 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Manenti, A. Stafford, L. De Gregorio, M. Gariboldi, F. S. Falvella, P. Avner, and T. A. Dragani Linkage Disequilibrium and Physical Mapping of Pas1 in Mice Genome Res., July 1, 1999; 9(7): 639 - 646. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |